🔎 Trials Near Me

Akèy › Melanom Uveal › Colorado

Etid klinik pou Melanom Uveal nan Colorado

7 etid pou Melanom Uveal ap chèche patisipan nan sit nan Colorado.

Vil nan Colorado

Tèks ofisyèl etid la (Anglè)

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

  • University of Colorado Cancer Center, Aurora
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06070012

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

  • SCRI Oncology Partners- Denver, Denver
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

  • SCRI - Denver, Denver
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 8, 2026 · NCT03947385

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • University of Colorado, Anschutz Medical Campus, Aurora
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • University of Colorado Hospital, Aurora
  • The Melanoma and Skin Cancer Institute, Englewood
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

  • University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora
  • The Melanoma & Skin Cancer Institute, Englewood
Ap rekriteFaz 2/3
Tout laj · Tout sèks · Mizajou Apr 2, 2026 · NCT06581406

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

  • Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 28, 2025 · NCT07136181

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.